TY - JOUR
T1 - Erratum
T2 - Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy (SLEEP DOI: 10.1093/sleep/zsaa206)
AU - Bogan, Richard K.
AU - Thorpy, Michael J.
AU - Dauvilliers, Yves
AU - Partinen, Markku
AU - Del Rio Villegas, Rafael
AU - Foldvary-Schaefer, Nancy
AU - Skowronski, Roman
AU - Tang, Lihua
AU - Skobieranda, Franck
AU - Šonka, Karel
N1 - Publisher Copyright:
© 2021 Oxford University Press. All rights reserved.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - In the originally published version of this manuscript, there was an error under the Efficacy heading. The following text should read: “randomized to placebo (1.00 [0.00, 4.45]) or to continue LXB treatment (1.08 [0.00, 7.88])” instead of “randomized to placebo (1.08 [0.00, 7.88]) or to continue LXB treatment (1.00 [0.00, 4.45]).” This has now been corrected online.
AB - In the originally published version of this manuscript, there was an error under the Efficacy heading. The following text should read: “randomized to placebo (1.00 [0.00, 4.45]) or to continue LXB treatment (1.08 [0.00, 7.88])” instead of “randomized to placebo (1.08 [0.00, 7.88]) or to continue LXB treatment (1.00 [0.00, 4.45]).” This has now been corrected online.
UR - http://www.scopus.com/inward/record.url?scp=85112125101&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112125101&partnerID=8YFLogxK
U2 - 10.1093/sleep/zsab033
DO - 10.1093/sleep/zsab033
M3 - Comment/debate
C2 - 34223903
AN - SCOPUS:85112125101
SN - 0161-8105
VL - 44
JO - Sleep
JF - Sleep
IS - 7
M1 - zsab033
ER -